raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:52416

Mantle cell lymphoma

Synonyms: LCM · MCL · Mantle zone lymphoma

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial, Not applicable
Age of onset
Adult
Status
active

Mantle cell lymphoma is a rare form of malignant non-Hodgkin lymphoma affecting B lymphocytes in the lymph nodes in a region called the ``mantle zone''.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMantle cell lymphomaLCM · MCL · Mantle zone lymphoma
frLymphome à cellules du manteauMCL
deMantelzell-LymphomMCL
esLinfoma de células del mantoLCM · Linfoma de la zona del manto · MCL
itLinfoma a cellule mantellariLCM · Linfoma della zona mantellare · MCL
nlMantelcellymfoomLCM · MCL · Mantelzonelymfoom
ptLinfoma das células do manto
plChłoniak z komórek płaszczaChłoniak strefy brzeżnej · LCM · MCL
csLymfom z plášťových buněkLCM · MCL · Lymfom z buněk plášťové zóny
ukЛімфома з мантійних клітинLCM · Лімфома мантійної зони · MCL
zh套细胞淋巴瘤套区淋巴瘤
trManto hücreli lenfomaLCM · MCL · Mantle zon lenfoması

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C83.1Especificvalidated
ICD-112A85.5Especificvalidated
MONDO0018876Evalidated
MeSHD020522Evalidated
UMLSC4721414Evalidated
GARD6969Evalidated
MedDRA10061275Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ATMDisease-causing somatic mutation(s) inAssessedHGNC:795ENSG0000014931160758511q22.3ATM serine/threonine kinase10706620[PMID]
CCND1Disease-causing somatic mutation(s) inAssessedHGNC:1582ENSG0000011009216846111q13.3cyclin D1
IGHDisease-causing somatic mutation(s) inAssessedHGNC:547714691014q32.33immunoglobulin heavy locus12601901[PMID]_11245476[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 100 0001.05 / 100 000FranceValue and classValidatedOTHERitut National du Cancer 2013[OTHER]
Annual incidence1-9 / 1 000 0000.8 / 100 000United StatesValue and classValidated28444739[PMID]_SEER Surveillance Epidemiology and End Results 2007-2013[OTHER]
Point prevalence1-9 / 100 0003.5 / 100 000EuropeValue and classValidated[EXPERT]_European Medicines Agency 2015[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

9 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0012191B-cell lymphoma
HP:0002716Lymphadenopathy
Frequent (79-30%)
HP:0005561Abnormality of bone marrow cell morphology
HP:0002039Anorexia
HP:0012378Fatigue
HP:0001945Fever
HP:0001744Splenomegaly
HP:0001824Weight loss
Occasional (29-5%)
HP:0011024Abnormality of the gastrointestinal tract

Run the differential on the 2 obligate / very frequent terms

Annotation source: 12548600[PMID]

7

Sources for this card